1calculated from analyst ratings published within the last 3 years
date | ticker | Buy Now | Company | Current price | Upside/Downside | Analyst Firm | Analyst & % Accurate | Price Target Change | Rating Change | Previous / Current Rating | Get Alert |
---|---|---|---|---|---|---|---|---|---|---|---|
03/25/2024 | GNPX | Buy Now | Genprex | $2.87 | 248.43% | HC Wainwright & Co. | Yi Chen | → $10 | Initiates | → Buy | Get Alert |
01/30/2023 | GNPX | Buy Now | Genprex | $2.87 | 4.53% | Dawson James | Jason Kolbert | → $120 | Initiates | → Buy | Get Alert |
The latest price target for Genprex (NASDAQ: GNPX) was reported by HC Wainwright & Co. on March 25, 2024. The analyst firm set a price target for $10.00 expecting GNPX to rise to within 12 months (a possible 248.43% upside). 1 analyst firms have reported ratings in the last year.
The latest analyst rating for Genprex (NASDAQ: GNPX) was provided by HC Wainwright & Co., and Genprex initiated their buy rating.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Genprex, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Genprex was filed on March 25, 2024 so you should expect the next rating to be made available sometime around March 25, 2025.
While ratings are subjective and will change, the latest Genprex (GNPX) rating was a initiated with a price target of $0.00 to $10.00. The current price Genprex (GNPX) is trading at is $2.87, which is within the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.